IBDEI0ZB ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17217,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,17218,0)
 ;;=V18.4^^88^1053^4
 ;;^UTILITY(U,$J,358.3,17218,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17218,1,4,0)
 ;;=4^V18.4
 ;;^UTILITY(U,$J,358.3,17218,1,5,0)
 ;;=5^FAM HX-MENTAL RETARDAT
 ;;^UTILITY(U,$J,358.3,17218,2)
 ;;=^340655
 ;;^UTILITY(U,$J,358.3,17219,0)
 ;;=V18.69^^88^1053^5
 ;;^UTILITY(U,$J,358.3,17219,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17219,1,4,0)
 ;;=4^V18.69
 ;;^UTILITY(U,$J,358.3,17219,1,5,0)
 ;;=5^FAM HX-OTH KIDNEY DIS
 ;;^UTILITY(U,$J,358.3,17219,2)
 ;;=^321532
 ;;^UTILITY(U,$J,358.3,17220,0)
 ;;=V18.61^^88^1053^6
 ;;^UTILITY(U,$J,358.3,17220,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17220,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,17220,1,5,0)
 ;;=5^FAM HX-POLYCYS KIDNEY
 ;;^UTILITY(U,$J,358.3,17220,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,17221,0)
 ;;=V18.2^^88^1053^7
 ;;^UTILITY(U,$J,358.3,17221,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17221,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,17221,1,5,0)
 ;;=5^FAMILY HX-ANEMIA
 ;;^UTILITY(U,$J,358.3,17221,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,17222,0)
 ;;=V18.7^^88^1053^8
 ;;^UTILITY(U,$J,358.3,17222,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17222,1,4,0)
 ;;=4^V18.7
 ;;^UTILITY(U,$J,358.3,17222,1,5,0)
 ;;=5^FAMILY HX-GU DISEASE NEC
 ;;^UTILITY(U,$J,358.3,17222,2)
 ;;=^295318
 ;;^UTILITY(U,$J,358.3,17223,0)
 ;;=V18.19^^88^1053^9
 ;;^UTILITY(U,$J,358.3,17223,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17223,1,4,0)
 ;;=4^V18.19
 ;;^UTILITY(U,$J,358.3,17223,1,5,0)
 ;;=5^FM HX ENDO/METAB DIS NEC
 ;;^UTILITY(U,$J,358.3,17223,2)
 ;;=^295312
 ;;^UTILITY(U,$J,358.3,17224,0)
 ;;=V18.8^^88^1053^10
 ;;^UTILITY(U,$J,358.3,17224,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17224,1,4,0)
 ;;=4^V18.8
 ;;^UTILITY(U,$J,358.3,17224,1,5,0)
 ;;=5^FM HX-INFECT/PARASIT DIS
 ;;^UTILITY(U,$J,358.3,17224,2)
 ;;=^295319
 ;;^UTILITY(U,$J,358.3,17225,0)
 ;;=V19.0^^88^1054^3
 ;;^UTILITY(U,$J,358.3,17225,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17225,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,17225,1,5,0)
 ;;=5^FAMILY HX-BLINDNESS
 ;;^UTILITY(U,$J,358.3,17225,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,17226,0)
 ;;=V19.19^^88^1054^8
 ;;^UTILITY(U,$J,358.3,17226,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17226,1,4,0)
 ;;=4^V19.19
 ;;^UTILITY(U,$J,358.3,17226,1,5,0)
 ;;=5^FAMILY HX-EYE DISORD NEC
 ;;^UTILITY(U,$J,358.3,17226,2)
 ;;=^340618
 ;;^UTILITY(U,$J,358.3,17227,0)
 ;;=V19.2^^88^1054^6
 ;;^UTILITY(U,$J,358.3,17227,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17227,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,17227,1,5,0)
 ;;=5^FAMILY HX-DEAFNESS
 ;;^UTILITY(U,$J,358.3,17227,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,17228,0)
 ;;=V19.3^^88^1054^7
 ;;^UTILITY(U,$J,358.3,17228,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17228,1,4,0)
 ;;=4^V19.3
 ;;^UTILITY(U,$J,358.3,17228,1,5,0)
 ;;=5^FAMILY HX-EAR DISORD NEC
 ;;^UTILITY(U,$J,358.3,17228,2)
 ;;=^295323
 ;;^UTILITY(U,$J,358.3,17229,0)
 ;;=V19.4^^88^1054^9
 ;;^UTILITY(U,$J,358.3,17229,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17229,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,17229,1,5,0)
 ;;=5^FAMILY HX-SKIN CONDITION
 ;;^UTILITY(U,$J,358.3,17229,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,17230,0)
 ;;=V19.5^^88^1054^1
 ;;^UTILITY(U,$J,358.3,17230,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17230,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,17230,1,5,0)
 ;;=5^FAM HX-CONGEN ANOMALIES
 ;;^UTILITY(U,$J,358.3,17230,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,17231,0)
 ;;=V19.6^^88^1054^2
 ;;^UTILITY(U,$J,358.3,17231,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17231,1,4,0)
 ;;=4^V19.6
 ;;
 ;;$END ROU IBDEI0ZB
